ReP USP - Resultado da busca

Artigo de periodico
Chronic environmental hypoxia attenuates innate immunity activation and renal injury in two CKD models (2023)
Zambom, Fernanda Florencia Fregnan; Albino, Amanda Helen; Tessaro, Helena Mendonca; Foresto-Neto, Orestes; Malheiros, Denise Maria Avancini Costa ; Camara, Niels Olsen Saraiva; Zatz, Roberto
Source: American journal of physiology-renal physiology. Unidade: FM
Subjects: NEFROPATIAS, DOR CRÔNICA, RIM, MODELOS ANIMAIS, ESTRESSE OXIDATIVO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
ZAMBOM, Fernanda Florencia Fregnan et al. Chronic environmental hypoxia attenuates innate immunity activation and renal injury in two CKD models. American journal of physiology-renal physiology, v. 325, n. 3, p. F283-F298, 2023Tradução . . Disponível em: https://observatorio.fm.usp.br/handle/OPI/56184. Acesso em: 11 nov. 2024.
APA
Zambom, F. F. F., Albino, A. H., Tessaro, H. M., Foresto-Neto, O., Malheiros, D. M. A. C., Camara, N. O. S., & Zatz, R. (2023). Chronic environmental hypoxia attenuates innate immunity activation and renal injury in two CKD models. American journal of physiology-renal physiology, 325( 3), F283-F298. doi:10.1152/ajprenal.00200.2022
NLM
Zambom FFF, Albino AH, Tessaro HM, Foresto-Neto O, Malheiros DMAC, Camara NOS, Zatz R. Chronic environmental hypoxia attenuates innate immunity activation and renal injury in two CKD models [Internet]. American journal of physiology-renal physiology. 2023 ; 325( 3): F283-F298.[citado 2024 nov. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56184
Vancouver
Zambom FFF, Albino AH, Tessaro HM, Foresto-Neto O, Malheiros DMAC, Camara NOS, Zatz R. Chronic environmental hypoxia attenuates innate immunity activation and renal injury in two CKD models [Internet]. American journal of physiology-renal physiology. 2023 ; 325( 3): F283-F298.[citado 2024 nov. 11 ] Available from: https://observatorio.fm.usp.br/handle/OPI/56184
Artigo de periodico
NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy (2013)
Okabe, Cristiene; Borges, Raquel Lerner; Almeida, Danilo Candido de; Fanelli, Camilla; Barlette, Grasiela Pedreira; Machado, Flavia Gomes; Arias, Simone Costa Alarcon; Malheiros, Denise Maria Avancini Costa; Câmara, Niels Olsen Saraiva ; Zatz, Roberto; Fujihara, Clarice Kazue
Source: American Journal of Physiology. Renal Physiology. Unidades: FM, ICB
Subjects: NEFROPATIAS, TÉCNICAS E PROCEDIMENTOS DE LABORATÓRIO, RIM (PATOLOGIA), RATOS WISTAR, MODELOS ANIMAIS, INSUFICIÊNCIA RENAL ANIMAL
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OKABE, Cristiene et al. NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy. American Journal of Physiology. Renal Physiology, v. 305, n. 2, p. F155-F163, 2013Tradução . . Disponível em: https://doi.org/10.1152/ajprenal.00491.2012. Acesso em: 11 nov. 2024.
APA
Okabe, C., Borges, R. L., Almeida, D. C. de, Fanelli, C., Barlette, G. P., Machado, F. G., et al. (2013). NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy. American Journal of Physiology. Renal Physiology, 305( 2), F155-F163. doi:10.1152/ajprenal.00491.2012
NLM
Okabe C, Borges RL, Almeida DC de, Fanelli C, Barlette GP, Machado FG, Arias SCA, Malheiros DMAC, Câmara NOS, Zatz R, Fujihara CK. NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy [Internet]. American Journal of Physiology. Renal Physiology. 2013 ; 305( 2): F155-F163.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1152/ajprenal.00491.2012
Vancouver
Okabe C, Borges RL, Almeida DC de, Fanelli C, Barlette GP, Machado FG, Arias SCA, Malheiros DMAC, Câmara NOS, Zatz R, Fujihara CK. NF-κB activation mediates crystal translocation and interstitial inflammation in adenine overload nephropathy [Internet]. American Journal of Physiology. Renal Physiology. 2013 ; 305( 2): F155-F163.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1152/ajprenal.00491.2012
Trabalho de evento-resumo periodico
Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload (2010)
Sousa, L B; Okabe, C; Sena, C R; Ventura, B H; Fanelli, Camilla; Malheiros, D M A C; Zatz, Roberto; Fujihara, Clarice Kazue
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: ÓXIDO NÍTRICO, SOLUÇÕES ELETROLÍTICAS, MODELOS ANIMAIS, RATOS, DOENÇA CRÔNICA (PREVENÇÃO E CONTROLE), ABLAÇÃO ANIMAL, NEFROPATIAS (PREVENÇÃO E CONTROLE), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
SOUSA, L B et al. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2010
APA
Sousa, L. B., Okabe, C., Sena, C. R., Ventura, B. H., Fanelli, C., Malheiros, D. M. A. C., et al. (2010). Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Sousa LB, Okabe C, Sena CR, Ventura BH, Fanelli C, Malheiros DMAC, Zatz R, Fujihara CK. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. 2010 ; 65 S56.[citado 2024 nov. 11 ]
Vancouver
Sousa LB, Okabe C, Sena CR, Ventura BH, Fanelli C, Malheiros DMAC, Zatz R, Fujihara CK. Renoprotective effect of two dosages of Losartan (L) in a model of crhonic kidney disease (CDK) by nitric oxide inhibition and and salt overload. Clinics. 2010 ; 65 S56.[citado 2024 nov. 11 ]
Trabalho de evento-resumo periodico
Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD) (2010)
Costa, S R; Valente, C P; Sena, C R; Fanelli, Camilla; Ventura, B H; Malheiros, D M A C; Zatz, Roberto; Fujihara, Clarice Kazue
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: INSUFICIÊNCIA RENAL CRÔNICA (INDUZIDO QUIMICAMENTE), MODELOS ANIMAIS, RATOS, MEDICAMENTO (EFEITOS ADVERSOS), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, S R et al. Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2010
APA
Costa, S. R., Valente, C. P., Sena, C. R., Fanelli, C., Ventura, B. H., Malheiros, D. M. A. C., et al. (2010). Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Costa SR, Valente CP, Sena CR, Fanelli C, Ventura BH, Malheiros DMAC, Zatz R, Fujihara CK. Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD). Clinics. 2010 ; 65 S38.[citado 2024 nov. 11 ]
Vancouver
Costa SR, Valente CP, Sena CR, Fanelli C, Ventura BH, Malheiros DMAC, Zatz R, Fujihara CK. Losartan (L) and hydrochlorotiazide (H) association (LH) arrests renal inhury in a model of very advanced chronic kidney disease (CKD). Clinics. 2010 ; 65 S38.[citado 2024 nov. 11 ]
Artigo de periodico
Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model (2010)
Fujihara, Clarice Kazue; Vieira Jr., Jose Mauro; Sena, Claudia Ramos; Ventura, Bianca Helena; Malheiros, Denise Maria; Zatz, Roberto
Source: American Journal of Nephrology. Unidade: FM
Subjects: ANGIOTENSINA II, DOENÇA CRÔNICA, EVOLUÇÃO CLÍNICA, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUJIHARA, Clarice Kazue et al. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model. American Journal of Nephrology, v. 32, n. 2, p. 95-102, 2010Tradução . . Disponível em: https://doi.org/10.1159/000315137. Acesso em: 11 nov. 2024.
APA
Fujihara, C. K., Vieira Jr., J. M., Sena, C. R., Ventura, B. H., Malheiros, D. M., & Zatz, R. (2010). Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model. American Journal of Nephrology, 32( 2), 95-102. doi:10.1159/000315137
NLM
Fujihara CK, Vieira Jr. JM, Sena CR, Ventura BH, Malheiros DM, Zatz R. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model [Internet]. American Journal of Nephrology. 2010 ; 32( 2): 95-102.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1159/000315137
Vancouver
Fujihara CK, Vieira Jr. JM, Sena CR, Ventura BH, Malheiros DM, Zatz R. Early Brief Treatment with Losartan plus Mycophenolate Mofetil Provides Lasting Renoprotection in a Renal Ablation Model [Internet]. American Journal of Nephrology. 2010 ; 32( 2): 95-102.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1159/000315137
Artigo de periodico
Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma (2010)
Otake, Andréia Hanada; Mattar, Ana Lucia; Freitas, Helano Carioca; Machado, Camila Maria Longo; Nonogaki, Suely; Fujihara, Clarice Kazue; Zatz, Roberto; Chammas, Roger
Source: Cancer Chemotherapy and Pharmacology. Unidade: FM
Subjects: ANGIOTENSINAS, MELANOMA, MODELOS ANIMAIS, FATORES DE CRESCIMENTO
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
OTAKE, Andréia Hanada et al. Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma. Cancer Chemotherapy and Pharmacology, v. 66, n. 1, p. 79-87, 2010Tradução . . Disponível em: https://doi.org/10.1007/s00280-009-1136-0. Acesso em: 11 nov. 2024.
APA
Otake, A. H., Mattar, A. L., Freitas, H. C., Machado, C. M. L., Nonogaki, S., Fujihara, C. K., et al. (2010). Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma. Cancer Chemotherapy and Pharmacology, 66( 1), 79-87. doi:10.1007/s00280-009-1136-0
NLM
Otake AH, Mattar AL, Freitas HC, Machado CML, Nonogaki S, Fujihara CK, Zatz R, Chammas R. Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma [Internet]. Cancer Chemotherapy and Pharmacology. 2010 ; 66( 1): 79-87.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s00280-009-1136-0
Vancouver
Otake AH, Mattar AL, Freitas HC, Machado CML, Nonogaki S, Fujihara CK, Zatz R, Chammas R. Inhibition of angiotensin II receptor 1 limits tumor-associated angiogenesis and attenuates growth of murine melanoma [Internet]. Cancer Chemotherapy and Pharmacology. 2010 ; 66( 1): 79-87.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1007/s00280-009-1136-0
Trabalho de evento-resumo periodico
High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac) (2010)
Castro, M S de; Fanelli, Camilla; Poppi, E P B; Fernandes, Bianca Helena Ventura; Machado, F G; Malheiros, D M A C; Fujihara, Clarice Kazue; Zatz, Roberto
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: INSUFICIÊNCIA RENAL CRÔNICA (INDUZIDO QUIMICAMENTE), NEFROPATIAS (INDUZIDO QUIMICAMENTE), MODELOS ANIMAIS, RATOS, RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
CASTRO, M S de et al. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2010
APA
Castro, M. S. de, Fanelli, C., Poppi, E. P. B., Fernandes, B. H. V., Machado, F. G., Malheiros, D. M. A. C., et al. (2010). High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Castro MS de, Fanelli C, Poppi EPB, Fernandes BHV, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. 2010 ; 65 S40.[citado 2024 nov. 11 ]
Vancouver
Castro MS de, Fanelli C, Poppi EPB, Fernandes BHV, Machado FG, Malheiros DMAC, Fujihara CK, Zatz R. High-dose losartan (L) provides no additional protection in a model of chronic kidney disease (CKD) caused by L treatment during lactation (LLac). Clinics. 2010 ; 65 S40.[citado 2024 nov. 11 ]
Trabalho de evento-resumo periodico
Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX) (2010)
Costa, S R; Souza, R A; Romagnoli, C; Fanelli, Camilla; Sena, C R; Ventura, B H; Malheiros, D M A C; Fujihara, Clarice Kazue; Zatz, Roberto
Source: Clinics. Conference titles: Simpósio "Avanços em Pesquisas Médicas dos Laboratórios de Investigação Médica do Hospital das Clínicas da FMUSP". Unidade: FM
Subjects: NEFROPATIAS (INDUZIDO QUIMICAMENTE), MODELOS ANIMAIS, RATOS, ABLAÇÃO ANIMAL, TÚBULOS RENAIS (PATOLOGIA), RESUMOS (EVENTOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, S R et al. Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2010
APA
Costa, S. R., Souza, R. A., Romagnoli, C., Fanelli, C., Sena, C. R., Ventura, B. H., et al. (2010). Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX). Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Costa SR, Souza RA, Romagnoli C, Fanelli C, Sena CR, Ventura BH, Malheiros DMAC, Fujihara CK, Zatz R. Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX). Clinics. 2010 ; 65 S38.[citado 2024 nov. 11 ]
Vancouver
Costa SR, Souza RA, Romagnoli C, Fanelli C, Sena CR, Ventura BH, Malheiros DMAC, Fujihara CK, Zatz R. Furosemide (F) is less effective than hydroclorothiazide (H) as adjuvant to losartan (L) in arresting the nephropathy associated with the 5/6 renal ablation model (NX). Clinics. 2010 ; 65 S38.[citado 2024 nov. 11 ]
Artigo de periodico
Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition (2007)
Mattar, Ana Lúcia; Machado, Flávia Gomes; Fujihara, Clarice Kazue; Malheiros, Denise Maria Avancini Costa; Zatz, Roberto
Source: Clinics. Unidade: FM
Subjects: INSUFICIÊNCIA RENAL CRÔNICA, RIM (PATOLOGIA), ANGIOTENSINA II, ÓXIDO NÍTRICO, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
MATTAR, Ana Lúcia et al. Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition. Clinics, v. 62, n. 6, p. 749-756, 2007Tradução . . Disponível em: https://doi.org/10.1590/s1807-59322007000600015. Acesso em: 11 nov. 2024.
APA
Mattar, A. L., Machado, F. G., Fujihara, C. K., Malheiros, D. M. A. C., & Zatz, R. (2007). Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition. Clinics, 62( 6), 749-756. doi:10.1590/s1807-59322007000600015
NLM
Mattar AL, Machado FG, Fujihara CK, Malheiros DMAC, Zatz R. Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition [Internet]. Clinics. 2007 ; 62( 6): 749-756.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/s1807-59322007000600015
Vancouver
Mattar AL, Machado FG, Fujihara CK, Malheiros DMAC, Zatz R. Persistent hypertension and progressive renal injury induced by salt overload after short term nitric oxide inhibition [Internet]. Clinics. 2007 ; 62( 6): 749-756.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1590/s1807-59322007000600015
Artigo de periodico
Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model (2007)
Fujihara, Clarice Kazue; Malheiros, Denise M. A. C.; Zatz, Roberto
Source: American Journal of Physiology. Renal Physiology. Unidade: FM
Subjects: PRESSÃO SANGUÍNEA, MODELOS ANIMAIS, SEGUIMENTOS, CATETRISMO, NEFRECTOMIA, INSUFICIÊNCIA RENAL CRÔNICA
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUJIHARA, Clarice Kazue e MALHEIROS, Denise M. A. C. e ZATZ, Roberto. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model. American Journal of Physiology. Renal Physiology, v. 292, n. 6, p. F1810-F1818, 2007Tradução . . Disponível em: https://doi.org/10.1152/ajprenal.00521.2006. Acesso em: 11 nov. 2024.
APA
Fujihara, C. K., Malheiros, D. M. A. C., & Zatz, R. (2007). Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model. American Journal of Physiology. Renal Physiology, 292( 6), F1810-F1818. doi:10.1152/ajprenal.00521.2006
NLM
Fujihara CK, Malheiros DMAC, Zatz R. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model [Internet]. American Journal of Physiology. Renal Physiology. 2007 ; 292( 6): F1810-F1818.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1152/ajprenal.00521.2006
Vancouver
Fujihara CK, Malheiros DMAC, Zatz R. Losartan-hydrochlorothiazide association promotes lasting blood pressure normalization and completely arrests long-term renal injury in the 5/6 ablation model [Internet]. American Journal of Physiology. Renal Physiology. 2007 ; 292( 6): F1810-F1818.[citado 2024 nov. 11 ] Available from: https://doi.org/10.1152/ajprenal.00521.2006
Trabalho de evento-resumo periodico
Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model (2007)
Costa, S. R.; Sena, C. R.; Fernandes, Bianca Helena Ventura; Carvalho, Lourdes de Freitas; Malheiros, D. M. A. C.; Zatz, Roberto; Fujihara, Clarice Kazue
Source: Clinics. Conference titles: Simpósio avanços em pesquisas médicas. Unidade: FM
Subjects: NEFROPATIAS, MODELOS ANIMAIS, RATOS, RESUMOS (SIMPÓSIOS)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
COSTA, S. R. et al. Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 2007
APA
Costa, S. R., Sena, C. R., Fernandes, B. H. V., Carvalho, L. de F., Malheiros, D. M. A. C., Zatz, R., & Fujihara, C. K. (2007). Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model. Clinics. São Paulo: Faculdade de Medicina, Universidade de São Paulo.
NLM
Costa SR, Sena CR, Fernandes BHV, Carvalho L de F, Malheiros DMAC, Zatz R, Fujihara CK. Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model. Clinics. 2007 ; 62 S39.[citado 2024 nov. 11 ]
Vancouver
Costa SR, Sena CR, Fernandes BHV, Carvalho L de F, Malheiros DMAC, Zatz R, Fujihara CK. Hydrochlorothiazide and losartan in combination prevent progressive nephropathy in the 5/6 renal ablation model. Clinics. 2007 ; 62 S39.[citado 2024 nov. 11 ]
Artigo de periodico
Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease (2005)
Vieira Junior, J. M.; Rodrigues, L. T.; Mantovani, E.; Dellê, H.; Mattar, A. L.; Malheiros, D. M. A. C.; Noronha, I. L.; Fujihara, C. K.; Zatz, Roberto
Source: Nephron Physiology. Unidade: FM
Subjects: HIPERTENSÃO (INDUZIDO QUIMICAMENTE), OXIDO NÍTRICO, MODELOS ANIMAIS, RATOS, RIM (LESÕES)
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
VIEIRA JUNIOR, J. M. et al. Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease. Nephron Physiology, v. 101, p. 82-91, 2005Tradução . . Acesso em: 11 nov. 2024.
APA
Vieira Junior, J. M., Rodrigues, L. T., Mantovani, E., Dellê, H., Mattar, A. L., Malheiros, D. M. A. C., et al. (2005). Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease. Nephron Physiology, 101, 82-91.
NLM
Vieira Junior JM, Rodrigues LT, Mantovani E, Dellê H, Mattar AL, Malheiros DMAC, Noronha IL, Fujihara CK, Zatz R. Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease. Nephron Physiology. 2005 ; 101 82-91.[citado 2024 nov. 11 ]
Vancouver
Vieira Junior JM, Rodrigues LT, Mantovani E, Dellê H, Mattar AL, Malheiros DMAC, Noronha IL, Fujihara CK, Zatz R. Statin monotherapy attenuates renal injury in a salt-sensitive hypertension model of renal disease. Nephron Physiology. 2005 ; 101 82-91.[citado 2024 nov. 11 ]
Trabalho de evento-resumo periodico
Glomerular hypertension , rather than high cholesterol (ch) levels, predominate in the genesis of glomerular sclerosis (gs) in analbuminemic (analb) rats with renal ablation (1989)
Fujihara, C K; Prado, E B A; Prado, M. J. B. A.; Santos, M M; Sanfelice, N F T; Padilha, R M; Pires, M C; Zatz, Roberto
Source: Kidney International. Conference titles: American Society of Nephrology Meeting. Unidade: FM
Subjects: MODELOS ANIMAIS, NEFROPATIAS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUJIHARA, C K et al. Glomerular hypertension , rather than high cholesterol (ch) levels, predominate in the genesis of glomerular sclerosis (gs) in analbuminemic (analb) rats with renal ablation. Kidney International. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 1989
APA
Fujihara, C. K., Prado, E. B. A., Prado, M. J. B. A., Santos, M. M., Sanfelice, N. F. T., Padilha, R. M., et al. (1989). Glomerular hypertension , rather than high cholesterol (ch) levels, predominate in the genesis of glomerular sclerosis (gs) in analbuminemic (analb) rats with renal ablation. Kidney International. Faculdade de Medicina, Universidade de São Paulo.
NLM
Fujihara CK, Prado EBA, Prado MJBA, Santos MM, Sanfelice NFT, Padilha RM, Pires MC, Zatz R. Glomerular hypertension , rather than high cholesterol (ch) levels, predominate in the genesis of glomerular sclerosis (gs) in analbuminemic (analb) rats with renal ablation. Kidney International. 1989 ;35( ja 1989): 428.[citado 2024 nov. 11 ]
Vancouver
Fujihara CK, Prado EBA, Prado MJBA, Santos MM, Sanfelice NFT, Padilha RM, Pires MC, Zatz R. Glomerular hypertension , rather than high cholesterol (ch) levels, predominate in the genesis of glomerular sclerosis (gs) in analbuminemic (analb) rats with renal ablation. Kidney International. 1989 ;35( ja 1989): 428.[citado 2024 nov. 11 ]
Trabalho de evento-resumo
Glomerular hypertrophy and lipid deposition in the genesis of glomerular sclerosis (gs) of experimental diabetes (dm) (1989)
Fujihara, C K; Padilha, R M; Santos, M M; Zatz, Roberto
Source: Abstracts. Conference titles: Annual Meeting of the American Society of Nephrology. Unidade: FM
Assunto: MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUJIHARA, C K et al. Glomerular hypertrophy and lipid deposition in the genesis of glomerular sclerosis (gs) of experimental diabetes (dm). 1989, Anais.. Washington: Faculdade de Medicina, Universidade de São Paulo, 1989. . Acesso em: 11 nov. 2024.
APA
Fujihara, C. K., Padilha, R. M., Santos, M. M., & Zatz, R. (1989). Glomerular hypertrophy and lipid deposition in the genesis of glomerular sclerosis (gs) of experimental diabetes (dm). In Abstracts. Washington: Faculdade de Medicina, Universidade de São Paulo.
NLM
Fujihara CK, Padilha RM, Santos MM, Zatz R. Glomerular hypertrophy and lipid deposition in the genesis of glomerular sclerosis (gs) of experimental diabetes (dm). Abstracts. 1989 ;[citado 2024 nov. 11 ]
Vancouver
Fujihara CK, Padilha RM, Santos MM, Zatz R. Glomerular hypertrophy and lipid deposition in the genesis of glomerular sclerosis (gs) of experimental diabetes (dm). Abstracts. 1989 ;[citado 2024 nov. 11 ]
Trabalho de evento-resumo periodico
Accelerated hypertension and severe glomerular damage in partially nephrectomized analbuminemic rats (1989)
Fujihara, C K; Marcondes, M; Prado, E B A; Prado, M. J. B. A.; Santos, M M; Sanfelice, N F T; Padilha, R M; Pires, M C; Zatz, Roberto
Source: Hypertension. Conference titles: Scientific Meeting of the Inter-American Society of Hypertension. Unidade: FM
Subjects: NEFROPATIAS, MODELOS ANIMAIS
A citação é gerada automaticamente e pode não estar totalmente de acordo com as normas
ABNT
FUJIHARA, C K et al. Accelerated hypertension and severe glomerular damage in partially nephrectomized analbuminemic rats. Hypertension. [S.l.]: Faculdade de Medicina, Universidade de São Paulo. . Acesso em: 11 nov. 2024. , 1989
APA
Fujihara, C. K., Marcondes, M., Prado, E. B. A., Prado, M. J. B. A., Santos, M. M., Sanfelice, N. F. T., et al. (1989). Accelerated hypertension and severe glomerular damage in partially nephrectomized analbuminemic rats. Hypertension. Faculdade de Medicina, Universidade de São Paulo.
NLM
Fujihara CK, Marcondes M, Prado EBA, Prado MJBA, Santos MM, Sanfelice NFT, Padilha RM, Pires MC, Zatz R. Accelerated hypertension and severe glomerular damage in partially nephrectomized analbuminemic rats. Hypertension. 1989 ;13( 5 ): 526.[citado 2024 nov. 11 ]
Vancouver
Fujihara CK, Marcondes M, Prado EBA, Prado MJBA, Santos MM, Sanfelice NFT, Padilha RM, Pires MC, Zatz R. Accelerated hypertension and severe glomerular damage in partially nephrectomized analbuminemic rats. Hypertension. 1989 ;13( 5 ): 526.[citado 2024 nov. 11 ]

USP Schools

ReP

Filtros

Departament

Authors

USP affiliated authors

Date published

Subjects

Source title

Conference titles

Indexado em